Introduction
Thromboembolism - Overview
Thromboembolism - Therapeutics Development
Thromboembolism - Therapeutics Assessment
Thromboembolism - Companies Involved in Therapeutics Development
Thromboembolism - Drug Profiles
Thromboembolism - Dormant Projects
Thromboembolism - Discontinued Products
Thromboembolism - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Thromboembolism, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Thromboembolism - Pipeline by Accu-Break Pharmaceuticals Inc, H1 2020
Thromboembolism - Pipeline by Acticor Biotech SAS, H1 2020
Thromboembolism - Pipeline by Bayer AG, H1 2020
Thromboembolism - Pipeline by Bristol-Myers Squibb Co, H1 2020
Thromboembolism - Pipeline by China Biologic Products Holdings Inc, H1 2020
Thromboembolism - Dormant Projects, H1 2020
Thromboembolism - Dormant Projects, H1 2020 (Contd..1), H1 2020
Thromboembolism - Discontinued Products, H1 2020

List of Figures
Number of Products under Development for Thromboembolism, H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Top 10 Molecule Types, H1 2020
Number of Products by Stage and Top 10 Molecule Types, H1 2020

Companies Mentioned
• Accu-Break Pharmaceuticals Inc
• Acticor Biotech SAS
• Bayer AG
• Bristol-Myers Squibb Co
• China Biologic Products Holdings Inc
• China Resources Emde Biological Pharmaceutical Co Ltd
• CSPC Pharmaceutical Group Ltd
• Daiichi Sankyo Co Ltd
• Espero BioPharma Inc
• EVAS Therapeutics LLC
• F. Hoffmann-La Roche Ltd
• GC Pharma
• Indiana Lysis Technologies LLC
• Ionis Pharmaceuticals Inc
• Laboratorios Farmaceuticos Rovi SA
• Les Laboratoires Servier SAS
• Ono Pharmaceutical Co Ltd
• Portola Pharmaceuticals Inc
• Tasly Pharmaceutical Group Co Ltd
• Tetherex Pharmaceuticals Corp
• Tianjin Pharmaceuticals Group Co Ltd
• Translational Sciences Inc
• Valeo Pharma Inc
• Verseon Corp